Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Dynamo claims to be the world's only 100% electric zero-emissions London black cab. It asserts that it uses Nissan's fully electric eNV200 Evalia MPV as a donor vehicle and converts it to a fully certified and compliant London 'Black Cab'. Dynamo argues that there are nearly 70,000 taxis in the UK, of which 4,000 have already converted to electric vehicles. Dynamo is competing to convert the remaining 66,000 into electric ones to gain profit and improve the environment. Dynamo has, to date, sold 170 vehicles in London, Liverpool, Coventry, Sheffield, and Nottingham. The company intends to become a competitor in the £4 billion taxi market. It states it will use the investment to procure a vast array of additional parts and equipment from a localised supply chain, increase its workforce, develop a second product in collaboration with Nissan/Renault Alliance, and strengthen its relationship with large automotive manufacturers.
days to go:
Expired
investment:
£1,768,035
MarketsFlow is a London and Boston based, highly innovative and performance driven Investment Manager platform. It is authorised regulated by the FCA, FRN 792373 and SEC. The company supports its clients to achieve financial goals by helping their money grow. In 2019, MarketsFlow became the winner of the Best Programmatic Trading Technology at WSL and Fund in New York for the third year in a row. MarketsFlow offers Managed Portfolios (GIA), IRAs and ISAs. The company is expecting that its Growth and High Growth portfolio is accessible. In the coming months, the company is about to launch its new mobile application to complement its Growth using M&A deals.
days to go:
Expired
investment:
£636,330
This Mum Runs (TMR) aims to get more women running. They currently have a 4,000 person strong community, nearly 3,000 mums running and over 30% of those are paying for TMR's courses. This Mum Runs offer over 50 runs a month in Bristol and Bath alone and are looking to expand to other cities by the end of the year.
days to go:
Expired
investment:
£103,230
Kalendit removes the middleman (agencies) and provides UK nurseries with temporary staff while helping them save up to 50% on staffing fees. Since September, over 150 users joined Kalendit, and it is continuing to add about two workers daily. This company had launched its services in November with four nurseries, and since then, have been successfully processed 49 bookings. With the funds raised, it will hire people and serve thirty nurseries in one year. By the fifth year, it wants to take 45% of the London market, which equates to 1400 nurseries.
days to go:
Expired
investment:
£82,180
Creating grand design homes in a factory that are high-tech, spacious and environmentally friendly. nHouse's modernised construction process means that less time can be spent building a home which has resulted in an increased production output and therefore greater efficiency. A nHouse modular home can be constructed within 12 to 16 weeks and they have already received more than 500 sales enquiries. The company has also attained BOPAS accreditation from the Council of Mortgage Lenders to reassure home insurers and mortgage providers.
days to go:
Expired
investment:
£307,170
Bricksave is a global platform that provides individuals with direct access to institutional-grade real estate investments previously only accessible to experienced, qualified, High Net Worth Investors. The company has a fully automated and functioning platform through which it hit the target of $4m and is aiming for the next milestone of $25m by the end of 2020. Moreover, the company has an experienced founding team of advisors backed by a successful track record. It also received a YoY growth in excess of 260%. With the proceeds, Bricksave will continue its aggressive growth strategy, boost its market position in current geographies and increase marketing efforts.
days to go:
Expired
investment:
£673,025
